A hard-won provision of the Affordable Care Act allows young adults to stay on their family’s health insurance until age 26. But after that, those without employer-sponsored insurance face an array of complicated choices, including whether to shop on the insurance plan exchange, apply for Medicaid, or roll the dice and go uninsured. Are you…
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
AI agents excel in operating within compliance frameworks, offloading structured tasks while escalating edge cases to human providers. They show great promise in helping reclaim clinical capacity and reduce the mounting administration associated with modern medicine. The post Easing Frontline Pressure: How AI Can Lift the Administrative Burden Off Care Teams appeared first on MedCity…
By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024. The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.
Lavonia Thomas, nursing informatics officer at MD Anderson Cancer Center, hopes that nurses will gain more access to ambient listening tools that listen in on patient conversations and then generate summaries for documentation purposes. These AI tools have become popular among physicians in the past couple years. The post This Hospital Exec Wants Nurses Should…
In this JAMA Viewpoints column, KFF’s Drew Altman, Ashley Kirzinger and Mollyann Brodie explore the power of health care affordability as an economic issue, how it has played out in recent election cycles, and the implications for the 2026 midterm elections.
As an industry, we need to ask hard questions. Are delegated vendors delivering on the promise of better, faster, more transparent decisions? Or are they simply moving the pain to another part of the system? The post The Delegation Dilemma: Why It’s Time for Health Plans to Rethink Vendor-Managed Utilization Management appeared first on MedCity…
The new Lilli App helps consumers manage polycystic ovary syndrome with meal plans, a symptom tracking tool and educational resources. The post Lilli Health Introduces App for Managing PCOS appeared first on MedCity News.
I was a little surprised that in the days of limitless content, AI, and all types of medical information being online a company could raise $15m to create a platform where actual doctors could answer specific questions that patients might have. Vikram Bhaskaran, the CEO is ex Pinterest and knows the consumer world well. Rohan…
Capital Rx has secured a $400 million investment, including a $252 million Series F round led by Wellington Management and General Catalyst. It is also rebranding as Judi Health to reflect its expansion beyond pharmacy benefits. The post Capital Rx Rebrands as Judi Health After Securing $400M Investment appeared first on MedCity News.